HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment

Y Shen, W Li - Drug design, development and therapy, 2018 - Taylor & Francis
Background Aim of this study was to prepare the hyaluronic acid and human serum albumin
modified erlotinib nanoparticles (ERT-HSA-HA NPs) delivery system by a precipitation …
被引用次数：52 相关文章

HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment

Y Shen, W Li - Drug Design, Development and Therapy, 2018 - go.gale.com
Background: Aim of this study was to prepare the hyaluronic acid and human serum albumin
modified erlotinib nanoparticles (ERT-HSA-HA NPs) delivery system by a precipitation …

HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment

Y Shen, W Li - Drug design, development and therapy, 2018 - pubmed.ncbi.nlm.nih.gov
Background Aim of this study was to prepare the hyaluronic acid and human serum albumin
modified erlotinib nanoparticles (ERT-HSA-HA NPs) delivery system by a precipitation …

HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment

Y Shen, W Li - Drug Design, Development and Therapy, 2018 - dovepress.com
Background: Aim of this study was to prepare the hyaluronic acid and human serum albumin
modified erlotinib nanoparticles (ERT-HSA-HA NPs) delivery system by a precipitation …

HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment.

Y Shen, W Li - Drug Design, Development and Therapy, 2018 - europepmc.org
Background Aim of this study was to prepare the hyaluronic acid and human serum albumin
modified erlotinib nanoparticles (ERT-HSA-HA NPs) delivery system by a precipitation …

HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment

Y Shen, W Li - Drug Design, Development and Therapy, 2018 - search.proquest.com
Background: Aim of this study was to prepare the hyaluronic acid and human serum albumin
modified erlotinib nanoparticles (ERT-HSA-HA NPs) delivery system by a precipitation …
[HTML] nih.gov

[HTML][HTML] HA/HSA co-modified erlotinib–albumin nanoparticles for lung cancer treatment

Y Shen, W Li - Drug Design, Development and Therapy, 2018 - ncbi.nlm.nih.gov
Background Aim of this study was to prepare the hyaluronic acid and human serum albumin
modified erlotinib nanoparticles (ERT-HSA-HA NPs) delivery system by a precipitation …

HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment.

Y Shen, W Li - Drug Design, Development and Therapy, 2018 - europepmc.org
Background Aim of this study was to prepare the hyaluronic acid and human serum albumin
modified erlotinib nanoparticles (ERT-HSA-HA NPs) delivery system by a precipitation …